A medical facility, research facility, company, or nonprofit organization subject to this chapter may not use a genome sequencer or software produced by or on behalf of:
- (1) a foreign adversary;
- (2) a state-owned enterprise of a foreign adversary;
- (3) a company or nonprofit organization domiciled within the borders of a country that is a foreign adversary; or
- (4) an owned or controlled subsidiary or affiliate of a company or nonprofit organization domiciled within the borders of a country that is a foreign adversary.
Added by Acts 2025, 89th Leg., R.S., Ch. 368 (H.B. 130), Sec. 1, eff. September 1, 2025.